Home LiteratureArticle Details
PMID: 7018570 Published · ppublish English Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Inactivation of RTEM beta-lactamase from Escherichia coli by clavulanic acid and 9-deoxyclavulanic acid.

Biochemistry ·Vol. 20 ·No. 11 ·1981-05-26 ·Pages 3214-9

Charnas RL, Knowles JR

Abstract

The interaction of the TEM-2 beta-lactamase with 9-deoxyclavulanic acid (3) and with both extensively labeled (2) and specifically labeled (1) clavulanic acid has been studied. The close similarity between 9-doexyclavulanate and clavulanate in kinetics, spectroscopic, and protein chemical terms show that the allyl alcohol group of clavulanate is irrelevant to its action as a beta-lactamase inactivator. Use of the radiolabeled samples of clavulanate shows that, of three irreversibly inactivated forms of the enzymes, two contain the whole clavulanate skeleton and the third only retains the carbon atoms of the original beta-lactam ring. These findings allow the complex interaction between clavulanic acid and the beta-lactamase to be defined more narrowly in chemical terms.

MeSH Terms
Clavulanic Acid Clavulanic Acids Escherichia coli/enzymology Kinetics Magnetic Resonance Spectroscopy Mass Spectrometry Spectrophotometry, Ultraviolet beta-Lactamase Inhibitors beta-Lactams/pharmacology
Chemicals
Clavulanic Acids beta-Lactamase Inhibitors beta-Lactams Clavulanic Acid 9-deoxyclavulanic acid
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Charnas R L
Knowles J R
Article Info
Journal
Biochemistry
Abbr.
Biochemistry
ISSN
0006-2960
Published
1981-05-26
Pages
3214-9
Language
English
Region
United States
NLM ID
0370623
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com